Abstract: Hepatocellular carcinoma （HCC） is a highly prevalent malignant tumor in China， and minimally invasive local intervention has become the core curative treatment for early- and intermediate-stage HCC. Leveraging its advantages of noninvasiveness， real-time operation， and bedside accessibility， ultrasound plays a pivotal role throughout the entire clinical pathway of screening for high-risk populations， qualitative diagnosis of focal lesions， ablation guidance， and efficacy monitoring throughout the entire post-treatment course. In this theme issue of Journal of Clinical Hepatology titled “Ultrasound diagnosis and treatment of hepatocellular carcinoma： Current status， challenges， and future prospects”， six leading experts in the field of ultrasound from China have been invited to contribute to a series of expert forums， systematically addressing the research hotspots， current bottlenecks， and translational pathways in this field from six key dimensions of integrated diagnosis and treatment in primary care， early differential diagnosis， intelligent imaging technologies， precision interventional ablation， standardized assessment of ablation efficacy， and bibliometric analysis and emerging techniques of contrast-enhanced ultrasound. With reference to the core viewpoints of the six reviews， this article provides a stratified commentary on the main trajectories of precise and intelligent development in HCC ultrasound， identifies key breakthroughs and unresolved challenges across various directions， and envisions a new landscape of multi-technological integration and collaborative clinical translation.